Daewoong, Wyeth are at odds over new drug agreement

Published: 2009-12-03 06:58:00

Updated: 2009-12-03 06:58:00

Daewoong Pharm said on November 30 the company plans to appeal the International Arbitration Court over the dispute arising from the Wyeth Pharmaceutical’s unilateral cancellation of the contract between a biopharmaceutical company in Scotland and Daewoong.

According to Daewoong, the Scotland ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK